Peng Xiao
Assistant Professor
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Peng Xiao is an Assistant Professor at the University of Louisiana at Lafayette, USA. His research primarily focuses on vaccine development and immunogenicity, particularly in the context of viral infections such as COVID-19 and HIV. Recent publications include studies on intranasal vaccines utilizing parainfluenza virus vectors and the assessment of various adjuvants for enhancing immune responses.
Articles (15)
Year:
2025
Year:
2025
CCR5-tropic simian/human immunodeficiency viruses (SHIV) with clade C transmitted/founder envelopes represent a critical tool for the investigation of HIV experimental vaccines and microbicides in nonhuman primates, although many such isolates lead to spontaneous viral control post infection. Here, we generated a high-titer stock of pathogenic SHIV-C109p5 by serial passage in two rhesus macaques (RM) and tested its virulence in aged monkeys. The co-receptor usage was confirmed before infecting five geriatric rhesus macaques (four female and one male). Plasma viral loads were monitored by reverse transcriptase-quantitative PCR (RT-qPCR), cytokines by multiplex analysis, and biomarkers of gastrointestinal damage by enzyme-linked immunosorbent assay. Antibodies and cell-mediated responses were also measured. Viral dissemination into tissues was determined by RNAscope. Intravenous SHIV-C109p5 infection of aged RMs leads to high plasma viremia and rapid disease progression; rapid decrease in CD4 + T cells, CD4 + CD8 + T cells, and plasmacytoid dendritic cells; and wasting necessitating euthanasia between 3 and 12 weeks post infection. Virus-specific cellular immune responses were detected only in the two monkeys that survived 4 weeks post infection. These were Gag-specific TNFα+CD8+, MIP1β+CD4+, Env-specific IFN-γ+CD4+, and CD107a+ T cell responses. Four out of five monkeys had elevated intestinal fatty acid binding protein levels at the viral peak, while regenerating islet-derived protein 3α showed marked increases at later time points in the three animals surviving the longest, suggesting gut antimicrobial peptide production in response to microbial translocation post infection. Plasma levels of monocyte chemoattractant protein-1, interleukin-15, and interleukin-12/23 were also elevated. Viral replication in gut and secondary lymphoid tissues was extensive. IMPORTANCE Simian/human immunodeficiency viruses (SHIV) are important reagents to study prevention of virus acquisition in nonhuman primate models of HIV infection, especially those representing transmitted/founder (T/F) viruses. However, many R5-tropic SHIV have limited fitness in vivo leading to many monkeys spontaneously controlling the virus post acute infection. Here, we report the generation of a pathogenic SHIV clade C T/F stock by in vivo passage leading to sustained viral load set points, a necessity to study pathogenicity. Unexpectedly, administration of this SHIV to elderly rhesus macaques led to extensive viral replication and fast disease progression, despite maintenance of a strict R5 tropism. Such age-dependent rapid disease progression had previously been reported for simian immunodeficiency virus but not for R5-tropic SHIV infections.
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Collaborators (10)
Bali Pulendran
Stanford University School of Medicine
ANGELA BRANCHE
Associate Professor of Medicine
University of Rochester
Christopher B. Fox
Associate Dean of Research
Utah State University
Francois Villinger
University of Louisiana at Lafayette
Sanjeev Gumber
-
Hao Duong
Associate Professor
Morehouse School of Medicine
Abhijit Date
Associate Professor of Pharmaceutical Sciences
University of Arizona
Samuel Wu
Chief Business Officer
-
Jarrod Mousa
Assistant Professor
University of Georgia
Mengyun Hu
Stanford University
Make your next move.
Prepare your application
Review drafts before you send them.